Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Return on Invested Capital (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Return on Invested Capital for 15 consecutive years, with 0.08% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Invested Capital rose 4.0% to 0.08% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.08%, a 4.0% increase, with the full-year FY2025 number at 0.08%, down 18.0% from a year prior.
  • Return on Invested Capital was 0.08% for Q4 2025 at Anika Therapeutics, down from 0.19% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.34% in Q2 2025 to a low of 0.52% in Q1 2025.
  • A 5-year average of 0.03% and a median of 0.03% in 2023 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: plummeted -163bps in 2021, then surged 32bps in 2025.
  • Anika Therapeutics' Return on Invested Capital stood at 0.02% in 2021, then crashed by -1082bps to 0.15% in 2022, then skyrocketed by 96bps to 0.01% in 2023, then tumbled by -1852bps to 0.12% in 2024, then surged by 32bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for ANIK's Return on Invested Capital are 0.08% (Q4 2025), 0.19% (Q3 2025), and 0.34% (Q2 2025).